# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Cerebral sarcoma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 25 results.
Children and Adolescents With Leukemia, Brain Tumors, and Sarcomas
Status: Not yet recruiting
Last Changed: Sep 26, 2019
First Received: Sep 24, 2019
Disease(s): Leukemia, Brain Tumor, Sarcoma, Childhood Cancer, Cancer, Adolescent Cancer
Intervention(s): Non-Interventional
Dose Escalation Study of CLR 131 in Children and Adolescents With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
Status: Recruiting
Last Changed: Feb 25, 2020
First Received: Mar 27, 2018
Disease(s): Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor, DIPG, Neuroblastoma, Ewing Sarcoma, Rhabdomyosarcoma, Osteosarcoma
Intervention(s): CLR 131
Locations: Lucile Packard Children's Hospital, Palo Alto, California, United States
Texas Children's Hospital, Houston, Texas, United States
University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States
Children's Hospital at Westmead, Westmead, New South Wales, Australia
Hospital for Sick Children, Toronto, Ontario, Canada
... and 1 other locations.
Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients.
Status: Not yet recruiting
Last Changed: Apr 29, 2020
First Received: Apr 29, 2020
Disease(s): Brain Cancer, Meningioma, Sarcoma
Locations: Centre Léon Bérard, Lyon, France
Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
Status: Recruiting
Last Changed: Aug 04, 2020
First Received: May 29, 2018
Disease(s): Glioblastomas, Sarcoma, Astrocytoma, Brain Cancer, Leukemia
Intervention(s): Enhanced Mindfulness Intervention, Psychoeducation
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Sunitinib in Sarcomas of the Central Nervous System
Status: Recruiting
Last Changed: Jun 26, 2020
First Received: Aug 22, 2018
Disease(s): Gliosarcoma, Central Nervous System Sarcoma
Intervention(s): Sunitinib, wGT3x-BT
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors
Status: Recruiting
Last Changed: Apr 03, 2020
First Received: Dec 31, 2015
Disease(s): Diffuse Intrinsic Pontine Glioma, Brain Tumor, Recurrent, Solid Tumor, Recurrent, Neuroblastoma, Recurrent, Refractory, Ewing Sarcoma, Recurrent, Refractory, Rhabdomyosarcoma, Recurrent, Refractory, Osteosarcoma, Recurrent, Refractory, Rhabdoid Tumor, Recurrent, Refractory
Intervention(s): Abemaciclib
Locations: Phoenix Children's Hospital, Phoenix, Arizona, United States
Children's Hospital Colorado, Aurora, Colorado, United States
Children's Healthcare of Atlanta, Egleston, Atlanta, Georgia, United States
Children's Healthcare of Atlanta, Scottish Rite, Atlanta, Georgia, United States
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Status: Recruiting
Last Changed: Jul 17, 2020
First Received: Apr 11, 2019
Disease(s): Neoplasms, Brain, Glioblastoma Multiforme, Glioblastoma of Cerebellum, Neoplasms, Astrocytoma, Astrocytoma, Cerebellar, Neuroectodermal Tumors, Neuroectodermal Tumors, Primitive, Cerebellar PNET, Childhood, Cerebellar Neoplasms, Cerebellar Neoplasms, Primary, Cerebellar Neoplasm, Malignant, Cerebellar Neoplasm Malignant Primary, Neoplasm Metastases, Neoplasm Malignant, Neoplasms, Neuroepithelial, Neoplasms, Germ Cell and Embryonal, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Central Nervous System Neoplasms, Primary, Central Nervous System Neoplasms, Malignant, Nervous System Neoplasms, Neoplasms by Site, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Medulloblastoma Recurrent, HSV, Virus, Pediatric Brain Tumor, Nervous System Cancer, Primitive Neuroectodermal Tumor (PNET) of Cerebellum
Intervention(s): G207
Locations: Children's of Alabama, Birmingham, Alabama, United States
Methionine PET/CT Studies In Patients With Cancer
Status: Recruiting
Last Changed: Jun 29, 2020
First Received: Feb 10, 2009
Disease(s): Brain Tumors and/or Solid Tumors Including, Brain Stem Glioma, High Grade CNS Tumors, Ependymoma, Medulloblastoma, Craniopharyngioma, Low Grade CNS Tumors, Hodgkin Lymphoma, Non Hodgkin Lymphoma, Ewing Sarcoma, Osteosarcoma, Rhabdomyosarcoma, Neuroblastoma, Other
Intervention(s): Methionine
Locations: St. Jude Children's Research Hospital, Memphis, Tennessee, United States
The Master Registry of Oncology Outcomes Associated With Testing and Treatment
Status: Not yet recruiting
Last Changed: May 29, 2020
First Received: Jul 22, 2019
Disease(s): Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer, Appendix Cancer, Brain Tumor, Glioblastoma, Astrocytoma, Bile Duct Cancer, Cholangiocarcinoma, Bladder Cancer, Bone Cancer, Synovial Sarcoma, Chondrosarcoma, Liposarcoma, Sarcoma, Kaposi, Sarcoma,Soft Tissue, Sarcoma, Osteosarcoma, CNS Cancer, Brain Stem Neoplasms, Breast Cancer, Cervical Cancer, Colorectal Cancer, Rectal Cancer, Colon Cancer, Esophageal Cancer, Esophagus Cancer, Cancer of Colon, Pancreatic Cancer, Cancer of Pancreas, Testis Cancer, Testicular Cancer, Ureter Cancer, Renal Cell Carcinoma, Kidney Cancer, Gestational Trophoblastic Tumor, Head and Neck Neoplasms, Parotid Tumor, Larynx Cancer, Tongue Cancer, Pharynx Cancer, Salivary Gland Cancer, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Multiple Myeloma, Non Hodgkin Lymphoma, Carcinoid Tumor, Lung Cancer, Neuroendocrine Tumors, Mesothelioma, Thyroid Cancer, Parathyroid Neoplasms, Adrenal Cancer, Small Bowel Cancer, Stomach Cancer, Liver Cancer, Hepatic Cancer, Melanoma, Skin Cancer, Unknown Primary Tumors, Uterine Cancer, Fallopian Tube Cancer, Ovarian Cancer, Prostate Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Waldenstrom Macroglobulinemia, Cancer, Advanced, Thymus Cancer, Nasopharyngeal Carcinoma, Multiple Endocrine Neoplasia, Pheochromocytoma, Small Cell Carcinoma, Pulmonary Carcinoma
Intervention(s): Biomarker Testing (L), Systemic Treatment (T), Patient Reported Outcomes (P)
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Recruiting
Last Changed: Aug 06, 2020
First Received: Oct 05, 2015
Disease(s): Breast Cancer, Cholangiocarcinoma, Colorectal Cancer, Head and Neck Neoplasms, Lymphoma, Large-Cell, Anaplastic, Melanoma, Neuroendocrine Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Papillary Thyroid Cancer, Primary Brain Tumors, Renal Cell Carcinoma, Sarcomas, Salivary Gland Cancers, Adult Solid Tumor
Intervention(s): Entrectinib
Locations: Western Regional Medical Center at Cancer Treatment Centers of America, Goodyear, Arizona, United States
Dignity Health St Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
Mayo Clinic, Scottsdale, Arizona, United States
City of Hope Cancer Center; Division of Medical Oncology & Experimental Therapeutics, Duarte, California, United States
Scripps Clinic, La Jolla, California, United States
... and 141 other locations.